Your browser doesn't support javascript.
loading
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Hammel, P; Kindler, H L; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M J; Park, J O; Hochhauser, D; Arnold, D; Oh, D-Y; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E M; McGuinness, D; Cui, K Y; Joo, S; Yoo, H K; Patel, N; Golan, T.
  • Hammel P; Department of Digestive Oncology, Hôpital Beaujon (AP-HP), Clichy, and University Paris VII, Paris, France. Electronic address: pascal.hammel@aphp.fr.
  • Kindler HL; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, USA.
  • Reni M; Department of Oncology, IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy.
  • Van Cutsem E; Division of Digestive Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium.
  • Macarulla T; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Hall MJ; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, USA.
  • Park JO; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hochhauser D; Department of Oncology, University College London Cancer Institute, London, UK.
  • Arnold D; Department of Oncology, Asklepios Tumorzentrum Hamburg Asklepios Klinik Altona, Hamburg, Germany.
  • Oh DY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Reinacher-Schick A; Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany.
  • Tortora G; Department of Medicine, Section of Medical Oncology, Azienda Ospedaliera Universitaria Integrata Verona, Verona and Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.
  • Algül H; Second Department of Internal Medicine, Klinikum rechts der Isar, Comprehensive Cancer Center Munich-TUM and Department of Internal Medicine II, Technische Universität München, Munich, Germany.
  • O'Reilly EM; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA.
  • McGuinness D; AstraZeneca, Cambridge, UK.
  • Cui KY; AstraZeneca, Gaithersburg, USA.
  • Joo S; Merck & Co., Inc., Kenilworth, USA.
  • Yoo HK; AstraZeneca, Cambridge, UK.
  • Patel N; AstraZeneca, Gaithersburg, USA.
  • Golan T; The Oncology Institute, Sheba Medical Center, Tel Aviv, Israel.
Ann Oncol ; 30(12): 1959-1968, 2019 12 01.
Article en En | MEDLINE | ID: mdl-31562758
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article